Because insulin-degrading peptide IDE is known to degrade insulin along with Aβ (Selkoe, 2001; Qiu and Folstein, 2006), in hyperinsulinemia, the binding of insulin to IDE may have interfered with Aβ degradation, leading to Aβ accumulation in the brain. The gene discussed is INS; the disease is hyperinsulinism.